We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Top Buys

Rank Stock Value
1
BEAM icon
Beam Therapeutics
BEAM
+$25.6M
2
PSFE icon
Paysafe
PSFE
+$12.2M
3
VIEW
View, Inc. Class A Common Stock
VIEW
+$11.9M
4
OUST icon
Ouster
OUST
+$9.91M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$8.09M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$53.1M
2
SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
+$27M
3
QTRX icon
Quanterix
QTRX
+$20.3M
4
SPRU icon
Spruce Power Holding Corp
SPRU
+$14.9M
5
SNRHU
Senior Connect Acquisition Corp. I Unit
SNRHU
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMPX
76
DELISTED
AEA-Bridges Impact Corp
IMPX
$2.46M 0.38%
250,000
– –
CFIV
77
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
$2.45M 0.38%
+250,000
New +$2.5M
HCCC
78
DELISTED
Healthcare Capital Corp. Class A common stock
HCCC
$2.42M 0.37%
+250,000
New +$2.43M
LFMD icon
79
LifeMD
LFMD
$174M
$2.41M 0.37%
152,174
-268,879
-64% -$4.84M
CFRX
80
DELISTED
ContraFect Corporation
CFRX
$2.4M 0.37%
+6,250
New +$2.7M
MANU icon
81
Manchester United
MANU
$3.74B
$2.36M 0.36%
+149,979
New +$2.53M
SNOW icon
82
Snowflake
SNOW
$116B
$2.29M 0.35%
+10,000
New +$2.67M
CYXT
83
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$2.23M 0.34%
224,914
+24,924
+12% +$261K
MP icon
84
MP Materials
MP
$9.73B
$2.16M 0.33%
+60,000
New +$2.22M
OLO
85
DELISTED
Olo Inc
OLO
$2.11M 0.32%
+80,000
New +$2.4M
ACHL
86
DELISTED
Achilles Therapeutics
ACHL
$2.07M 0.32%
+125,000
New +$2.07M
CNTB
87
Connect Biopharma Holdings
CNTB
$135M
$2.04M 0.31%
+110,000
New +$1.87M
COUR icon
88
Coursera
COUR
$1.52B
$2.02M 0.31%
+45,000
New +$2.02M
ORGN
89
DELISTED
Origin Materials
ORGN
$2.02M 0.31%
6,667
– –
FNCH
90
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$2.02M 0.31%
+4,167
New +$2.12M
RMGB
91
DELISTED
RMG Acquisition Corp. II Class A Ordinary Shares
RMGB
$2M 0.31%
+199,992
New +$2.16M
NSTB
92
DELISTED
Northern Star Investment Corp. II
NSTB
$2M 0.31%
+200,000
New +$2.05M
TSIBU
93
DELISTED
Tishman Speyer Innovation Corp. II Unit
TSIBU
$2M 0.31%
+200,000
New +$2.06M
NXU.U
94
DELISTED
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
$2M 0.31%
+200,000
New +$2.09M
FVAM
95
DELISTED
5:01 Acquisition Corp
FVAM
$2M 0.31%
200,000
– –
CFFVU
96
DELISTED
CF Acquisition Corp. V Unit
CFFVU
$2M 0.31%
+200,000
New +$2.07M
GRSV
97
DELISTED
Gores Holdings V, Inc.
GRSV
$2M 0.31%
200,000
– –
ARRWU
98
DELISTED
Arrowroot Acquisition Corp. Unit
ARRWU
$1.99M 0.31%
+200,000
New +$2M
NSTC.U
99
DELISTED
Northern Star Investment Corp. III Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTC.U
$1.99M 0.31%
+200,000
New +$2M
MIT.U
100
DELISTED
Mason Industrial Technology, Inc. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant to purchase one share of Class A common stock
MIT.U
$1.99M 0.31%
+200,000
New +$2.03M
2 3
4
5 6

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.